Jeremy Green, 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), bought 194,176 shares at $12.50 ($1.9M) on 2016-07-06, disclosed to the SEC on 2016-07-07.
Open-market purchase of $1.9M SYRS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 40,420 | $0 | 0.0% |
| 2 | $12.50 | 9,373 | $117K | 6.1% |
| 3 | $12.50 | 144,383 | $1.8M | 93.9% |
| Total | $9.90 avg | 194,176 | $1.9M | 100% |
| Filing → |
| ADCT | BUY | 2024-12-13 | $419K | — | Filing → |
| STTK | BUY | 2024-12-06 | $333K | — | Filing → |
| STTK | SELL | 2024-12-06 | $333K | — | Filing → |